CD9 trogocytosis from tumor cells onto NK cells were shown to promote reactivation of A disintegrin and metalloprotease (ADAM) 10 and 17 which both participate in the shedding of NK ligands and NK receptors. The gene discussed is CD9; the disease is neoplasm.